Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older.
- You have been diagnosed with a type of lung scarring or inflammation condition (called interstitial lung disease, or ILD) by a lung specialist, a rheumatologist, or a radiologist.
- Your ILD falls into one of these specific types: idiopathic pulmonary fibrosis (IPF), ILD related to an autoimmune or connective tissue disease, unclassified ILD, ILD caused by a medication, lymphangioleiomyomatosis (LAM), or ILD related to sarcoidosis.
Who may not be able to join:
- You are under 18 years of age.
- You are unable to give your personal consent to take part in the trial yourself, in person.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pin-Kuei Fu, MD., Ph.D, Taichung Veterans General Hospital
Phone: 04-23592525
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
All-cause mortality; Annual rate of acute exacerbation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.